Tempus expands AI platform to six new cancer types for clinical insights
Go back to Tempus expands AI platform to six new cancer types for clinical insights| StemCells, Inc. (NASDAQ: TEM) | Delayed: 48.26 +0.41 (0.86%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $47.85 | 52 Week High | $0.45 | |||
| Open | $47.00 | 52 Week Low | $0.37 | |||
| Day High | $48.44 | P/E | N/A | |||
| Day Low | $46.68 | EPS | $-0.31 | |||
| Volume | 584,541 | |||||

